The objective of this work package is to envisage a multidisciplinary platform to federate the necessary expertise and competences within pharmaceutical sciences to support drug development for the pediatric population and to facilitate drug evaluation in children by providing appropriate age related formulation.
This work package aims at establishing the future model of paediatric formulation research platform to expedite the adoption of innovative platforms/technologies for better and safer dosage forms for children. It will be in the contest of a unique and complementary research infrastructure with the necessary expertise and competences to support drug development for the paediatric population and to facilitate drug evaluation in children by providing appropriate age related formulation.
The strategic objective of this WP would be to create a coordinated EU paediatric formulation platform, as part of a Paediatric Infrastructure, bringing together the major European research groups/networks (such as European Pediatric Formulation Initiatives (EuPFI) to join forces and ultimately, to respond in a concerted way to scientific questions in order to tackle the challenges in developing paediatric formulations and to increase its visibility and impact.
The reference person for this WP is Valeria Pignataro ([email protected]).